In summary, elevations in IgE are common in IgG4-RD (affecting over half of patients) and represent a valuable biomarker for both diagnosis and relapse prediction, as robustly demonstrated by Culver et al.’s prospective cohort. The gene discussed is IGHE; the disease is immunoglobulin G4-related sclerosing disease.